Despite adiponectin having numerous renoprotective effects, adiponectin levels are paradoxically increased in CKD and are positively correlated with albuminuria, CKD stage, and mortality, independent of body mass index (BMI) (58, 111). This evidence concerns the gene ADIPOQ and chronic kidney disease.